Vanguard Group Inc boosted its position in Express Scripts Holding Co (NASDAQ:ESRX) by 1.5% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 40,305,179 shares of the company’s stock after purchasing an additional 580,336 shares during the period. Vanguard Group Inc owned about 7.15% of Express Scripts worth $3,829,396,000 as of its most recent SEC filing.
A number of other hedge funds have also recently modified their holdings of the business. Capital International Investors boosted its stake in Express Scripts by 370.4% in the third quarter. Capital International Investors now owns 11,842,955 shares of the company’s stock valued at $1,125,199,000 after acquiring an additional 9,325,455 shares during the last quarter. Abrams Capital Management L.P. purchased a new position in Express Scripts in the second quarter valued at about $204,846,000. Canada Pension Plan Investment Board boosted its stake in Express Scripts by 124.5% in the second quarter. Canada Pension Plan Investment Board now owns 1,971,200 shares of the company’s stock valued at $152,196,000 after acquiring an additional 1,093,200 shares during the last quarter. FMR LLC boosted its stake in Express Scripts by 72.0% in the third quarter. FMR LLC now owns 2,442,388 shares of the company’s stock valued at $232,051,000 after acquiring an additional 1,022,548 shares during the last quarter. Finally, BlackRock Inc. boosted its stake in Express Scripts by 1.5% in the second quarter. BlackRock Inc. now owns 35,424,185 shares of the company’s stock valued at $2,735,103,000 after acquiring an additional 538,578 shares during the last quarter. 84.89% of the stock is owned by institutional investors and hedge funds.
A number of analysts recently commented on ESRX shares. Zacks Investment Research restated a “buy” rating and set a $109.00 price target on shares of Express Scripts in a research note on Tuesday, November 13th. BidaskClub upgraded shares of Express Scripts from a “hold” rating to a “buy” rating in a research note on Tuesday, September 18th. ValuEngine upgraded shares of Express Scripts from a “hold” rating to a “buy” rating in a research note on Monday, September 17th. Royal Bank of Canada set a $101.00 price target on shares of Express Scripts and gave the company a “buy” rating in a research note on Thursday, November 1st. Finally, Cowen reiterated a “buy” rating and issued a $88.00 target price on shares of Express Scripts in a research note on Friday, November 2nd. One investment analyst has rated the stock with a sell rating, fourteen have issued a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. Express Scripts presently has a consensus rating of “Hold” and a consensus target price of $92.14.
In related news, Director Mahon Thomas P. Mac sold 5,234 shares of the stock in a transaction that occurred on Wednesday, November 7th. The shares were sold at an average price of $99.50, for a total value of $520,783.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 0.79% of the company’s stock.
ESRX stock traded up $0.21 during mid-day trading on Friday, reaching $99.16. 123,287 shares of the stock traded hands, compared to its average volume of 4,203,944. The company has a quick ratio of 0.65, a current ratio of 0.77 and a debt-to-equity ratio of 0.63. The stock has a market capitalization of $54.65 billion, a price-to-earnings ratio of 13.93, a price-to-earnings-growth ratio of 1.22 and a beta of 0.88. Express Scripts Holding Co has a one year low of $66.93 and a one year high of $101.73.
Express Scripts (NASDAQ:ESRX) last issued its earnings results on Wednesday, October 31st. The company reported $2.43 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.42 by $0.01. Express Scripts had a net margin of 4.83% and a return on equity of 25.43%. The company had revenue of $25.56 billion for the quarter, compared to analysts’ expectations of $25.11 billion. During the same period in the prior year, the business earned $2.51 EPS. The firm’s quarterly revenue was up 3.6% on a year-over-year basis. As a group, equities research analysts expect that Express Scripts Holding Co will post 9.08 EPS for the current year.
TRADEMARK VIOLATION NOTICE: “Express Scripts Holding Co (ESRX) Holdings Raised by Vanguard Group Inc” was originally posted by Fairfield Current and is owned by of Fairfield Current. If you are accessing this piece of content on another site, it was copied illegally and republished in violation of United States & international copyright laws. The legal version of this piece of content can be read at https://www.fairfieldcurrent.com/news/2018/12/14/express-scripts-holding-co-esrx-holdings-raised-by-vanguard-group-inc.html.
Express Scripts Profile
Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company’s PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.
Featured Article: How Short Selling Works
Want to see what other hedge funds are holding ESRX?Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Co (NASDAQ:ESRX).
Receive News & Ratings for Express Scripts Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Express Scripts and related companies with MarketBeat.com’s FREE daily email newsletter.